Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

LB 42708

  • Zoom
    LB 42708
  • LB 42708
Cat No: 16428
Biochemicals - Small Molecule Inhibitors
Cayman

Farnesylation, the post-translational addition of a 15-carbon isoprenyl group, alters the function of several proteins, including Ras proteins.{21707,26419} LB 42708 is a potent inhibitor of farnesyltransferase (FTase), blocking farnesylation of H-Ras,...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • [1-[[1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]-4-morpholinyl-methanone
Correlated keywords:
  • intracellular signaling angiogenesis cancer inflammation arthritis biochemical inhibit inhibitor faresylation post-translational addition 15-carbon isoprenyl protein Ras LB42708 farnesyltransferase farnesyl transferase FTase H-Ras N-Ras K-Ras-4B LPS IFN-? activations NF-?B NF?B downstream RAW 264.7 RAW264.7 mouse macrophage mice Ras-dependent endothelial cell VEGF-mediated in vitro in vivo IFN? HRas NRas KRas KRas4B protein lipidation
Product Overview:
Farnesylation, the post-translational addition of a 15-carbon isoprenyl group, alters the function of several proteins, including Ras proteins.{21707,26419} LB 42708 is a potent inhibitor of farnesyltransferase (FTase), blocking farnesylation of H-Ras, N-Ras, and K-Ras4B with IC50 values of 0.8, 1.2, and 2.0 nM, respectively.{27038} It displays over 50,000-fold selectivity for FTase over geranylgeranyltransferase I.{27038} LB 42708 prevents the farnesylation of H-Ras in response to LPS plus IFN-γ (IC50 = 10 nM), preventing activation of NF-κB as well as downstream signaling.{27038} These effects are obtained both in RAW 264.7 mouse macrophages and in mice.{27038} LB42708 also inhibits Ras-dependent signaling in endothelial cells, stopping VEGF-mediated angiogenesis both in vitro and in vivo.{27039}
Size 1 mg
Shipping dry ice
CAS Number 226929-39-1
Molecular Formula C30H27BrN4O2
SMILES O=C(C1=CN(CC2=CN=CN2CC3=CC=C(Br)C=C3)C=C1C4=CC=CC5=C4C=CC=C5)N6CCOCC6
Molecular Weight 555,5
Formulation A crystalline solid
Purity ≥98%
Custom Code 2903.99
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : LB 42708 There are 6 products.

Search